Ascendis Pharma A-S
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $245,179 | $213,634 | $158,045 | $100,954 |
Gross Profit | 217,981 | 191,280 | 126,598 | 83,437 |
EBITDA | 14,581 | -53,353 | 2,319 | -44,234 |
EBIT | 9,803 | -57,372 | -1,989 | -48,779 |
Net Income | -33,247 | -60,989 | -38,855 | -94,626 |
Net Change In Cash | 245,179 | 213,634 | 158,045 | 100,954 |
Free Cash Flow | 67,373 | 2,100 | -11,679 | -15,016 |
Cash | 615,778 | 539,092 | 494,046 | 517,923 |
Basic Shares | 61,380 | 60,989 | 63,911 | 60,018 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $691,710 | $363,641 | $266,718 | $51,174 |
Gross Profit | 588,530 | 319,383 | 222,323 | 39,037 |
EBITDA | -113,895 | -290,023 | -411,168 | -529,177 |
EBIT | -130,892 | -307,737 | -430,079 | -546,691 |
Net Income | -219,034 | -378,084 | -481,447 | -583,194 |
Net Change In Cash | 691,710 | 363,641 | 266,718 | 51,174 |
Free Cash Flow | 43,619 | -307,624 | -469,803 | -510,188 |
Cash | 615,778 | 559,543 | 392,164 | 444,767 |
Basic Shares | 60,607 | 57,891 | 56,287 | 56,071 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.55 |
2025-09-30 | -$1 |
2025-06-30 | -$0.64 |
